Progenics Pharmaceuticals Competitors and Similar CompaniesClear all
Halozyme Therapeutics's competitors and similar companies include Biocon.
 Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. | ||
Founding Date | Founding Date 1998 | Founding Date 1978 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more |
Employees | Employees 373157% increase | Employees 16,5612% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) ₹167.8b (FY, 2026) |
Cost of goods | Cost of goods $228.8m (FY, 2025) | Cost of goods ₹56.9b (FY, 2026) |
Gross profit | Gross profit $1.2b (FY, 2025) | Gross profit ₹115.8b (FY, 2026) |
Net income | Net income $316.9m (FY, 2025) | Net income ₹3.7b (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase
Biocon is a company that develops and manufactures biopharmaceutical products.
View company